Responses

Download PDFPDF

A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Efficacy of magnesium sulphate
    Dear Editor

    I was interested to read the published article concerning the use of IV magnesium in refractory VF [1]. However I am puzzled about the possible inclusion of episodes of torsades de point in the VF study group. The differentiation of torsades from VF in an ambulance must be extremely difficult and the text does not elucidate on the accuracy of monitor reading. Neither is mention made of any verification system for...

    Show More
    Conflict of Interest:
    None declared.